NCT02891668View on ClinicalTrials.gov

Hypothyroidism, Metabolism and Quality of Life - Focus on QOL, REE, Cognitive Function and Body Composition

CompletedOBSERVATIONAL
Enrollment

42

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

May 20, 2018

Study Completion Date

May 20, 2018

Conditions
Hypothyroidism
Interventions
DRUG

Levothyroxine treatment

Eltroxin/Euthyrox is part of the normal treatment for hypothyroidism, and the patient is treated equally, whether he/she participates or not.

Trial Locations (1)

DK-2730

Department of internal Medicine, Herlev Hospital, Herlev

All Listed Sponsors
lead

Herlev Hospital

OTHER

NCT02891668 - Hypothyroidism, Metabolism and Quality of Life - Focus on QOL, REE, Cognitive Function and Body Composition | Biotech Hunter | Biotech Hunter